Imagine a world where the body’s own cleanup crew could be trained to target and eliminate harmful cells, such as those driving cancer or autoimmune disorders, with pinpoint accuracy. This isn’t a distant dream but a reality being shaped by groundbreaking research into a protein-based tool called
In a world grappling with the escalating burden of metabolic diseases, innovative solutions are urgently needed to address conditions like type 2 diabetes, obesity, non-alcoholic fatty liver disease, and certain cancers, which collectively affect millions globally and strain healthcare systems.
This how-to guide aims to equip healthcare professionals, researchers, and interested individuals with a clear understanding of how artificial intelligence (AI) can transform anticoagulation therapy for patients with atrial fibrillation (AF). By following the structured steps outlined, readers will
In an era where pharmaceutical innovation faces mounting pressure to deliver faster and more cost-effective solutions, digital twins have emerged as a groundbreaking force in reshaping clinical trials, offering a transformative approach to drug development. These virtual patient models, crafted
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a deep understanding of technology and innovation in the industry, has positioned him as a leading voice in cancer research. Today, we’ll dive into his
In the fast-paced realm of healthcare innovation, a remarkable partnership between Singapore-based Nanyang Biologics (NYB), global digital infrastructure giant Equinix, and technology leader Hewlett Packard Enterprise (HPE) is capturing attention across the industry. This collaboration has given
Imagine a child unable to attend school or play with friends due to the throbbing pain of a migraine, a condition often dismissed as just a headache but capable of derailing young lives with symptoms like nausea and sensitivity to light. This debilitating neurological disorder affects roughly one
In the rapidly evolving field of autoimmune disease treatment, Baricitinib, an oral Janus kinase (JAK) inhibitor, has carved out a significant role as a promising therapy for conditions such as rheumatoid arthritis and atopic dermatitis. For countless patients, particularly those in high-risk
Imagine a world where a silent, deadly disease like ovarian cancer, which affects thousands of women each year, could be caught in its earliest stages with just a simple blood draw, offering hope for timely intervention. This devastating illness, often striking women over 50, frequently goes
Picture a world where a robotic dog doesn’t just wag a mechanical tail but steps into disaster zones to save lives or guides someone with visual impairment through a bustling city street, transforming the way we approach human assistance. At Arizona State University (ASU), this compelling vision is
ITCurated uses cookies to personalize your experience on our website. By continuing to use this site, you agree to our Cookie Policy